Kaikun Wei - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kaikun Wei

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Trends in Biotechnology|March 16, 2023

Biosimilars: navigating the regulatory maze across two worldsKaikun Wei, Yazhen Kou, Hongjin Kan, et al.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|August 28, 2002

[Mutation of LoopAB in HuIFN 1c/86D and enhancement of antiviral activity]Rong Hu, Xuejun Ma, Kaikun Wei, et al.

Antibody Therapeutics|September 8, 2023

Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305Zhouyi Wu, Gangling Xu, Wu He, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Trends in Biotechnology|March 16, 2023

Biosimilars: navigating the regulatory maze across two worldsKaikun Wei, Yazhen Kou, Hongjin Kan, et al.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|August 28, 2002

[Mutation of LoopAB in HuIFN 1c/86D and enhancement of antiviral activity]Rong Hu, Xuejun Ma, Kaikun Wei, et al.

Antibody Therapeutics|September 8, 2023

Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305Zhouyi Wu, Gangling Xu, Wu He, et al.

Pageof 1